相关实验视频

Updated: May 16, 2025

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

与腺A2B受体的同时不激活的4-1BB刺激增强了CD8+T细胞抗瘤反应

Jihae Ahn¹, Ping Xie¹, Siqi Chen¹

¹Department of Medicine; Hematology/Oncology Division, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, United States of America.

The Journal of clinical investigation

|April 3, 2025

概括

激活4-1BB (CD137) 增强了CD8+ T细胞的抗瘤反应. 删除腺A2B受体 (A2BR) 通过维持代谢需求,可以提高T细胞存活率和采用细胞疗法的疗效.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
代谢重编程代谢重编程

背景情况:

用激素抗体激活4-1BB (CD137) 受体可以增强CD8+ T细胞抗瘤免疫力.
在T细胞反应的4-1BB介导强化背后的精确机制需要进一步阐明.

研究的目的:

为了研究 CD8+ T 细胞中由 4-1BB 激动作用引起的代谢脆弱性.
探索腺A2B受体 (A2BR) 在4-1BB共刺激期间调节CD8+T细胞功能的作用及其对采用细胞疗法 (ACT) 的影响.

主要方法:

在持续的抗原刺激下,用激进的4-1BB抗体对激活的CD8+T细胞进行治疗.
通过谷氨 (GSH) 和谷氨过氧化酶4 (GPX4) 抑制的代谢脆弱性的评估.
在4-1BB共刺激和ACT.的背景下,腺素A2B受体 (A2BR) 的遗传删除.

主要成果:

激动性4-1BB治疗增加了对CD8+T细胞中氧化还原干扰的代谢脆弱性.
在ACT中,A2BR的遗传删除显著改善了CD8+T细胞存活率,扩张和抗瘤功效.
A2BR删除通过GSH/GPX4轴维持了与4-1BB共刺激相关的代谢需求,减轻了T细胞耗尽.

结论:

腺A2B受体 (A2BR) 途径在代谢重编程中至关重要,在4-1BB辅助刺激时增强GSH/GPX4级联.
结合A2BR删除与4-1BB激素增强了CD8+效应T细胞的存活和扩张,为改善ACT中的抗瘤反应提供了一个有希望的策略.
准A2BR通路代表了微调CD8+T细胞介导的抗瘤免疫的新方法.

关键词:

适应性免疫是一种适应性免疫.免疫学免疫学免疫学免疫治疗是一种免疫疗法.在瘤学瘤学.在T细胞,T细胞.

更多相关视频

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...